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Abstract
Nitric oxide (NO) was discovered as an endothelium‐derived relaxing factor more than 
two decades ago. Since then, it has been shown to participate in many pathways. NO has 
been described as a key mediator of different pathways in the central nervous system 
(CNS) in both healthy and diseased processes. The three isoforms of nitric oxide synthase 
differ in their activity patterns and expression in different cells. Neuronal nitric oxide syn‐
thase (nNOS) is localized in synaptic spines, astrocytes, and the loose connective tissue sur‐
rounding blood vessels in the brain; eNOS is present in both cerebral vascular endothelial 
cells and motor neurons; and iNOS is induced in astrocytes and microglia under patho‐
logical conditions. During physiological processes, NO produced by eNOS/nNOS, respec‐
tively, controls blood flow activation, and act as a messenger during long‐term potentiation 
(LTP). However, under pathological conditions, eNOS appears to be impaired, leading 
to a reduction in blood flow and, consequently, low oxygen/metabolites delivery, efflux 
of toxicological agents from the brain tissue and disturbance in the blood‐brain barrier. 
The NO produced by iNOS in glial cells and nNOS, which triggers the NMDA‐excitotoxic 
pathway, combines with superoxide anion and results in peroxynitrite synthesis, a potent 
free radical that contributes to tissue damage in the brain. Here, we intend to show the con‐
troversial role of the nitric oxide delivered by the three isoforms of the nitric oxide synthase 
in the CNS, assess its impact under healthy/pathological conditions and speculate on its 
possible sequela, particularly in long‐term cognitive decline.
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1. Introduction
Three isoforms of nitric oxide synthase (NOS) have been identified: two constitutive enzymes, 
neuronal NOS (nNOS) and endothelial NOS (eNOS), and one inducible enzyme (iNOS). 
These three isoforms of the enzyme nitric oxide synthase (NOS) that are present in the cen‐
tral nervous system (CNS) can produce nitric oxide (NO). eNOS is expressed in the vascular 
endothelium and choroid plexus; neuronal NOS is mainly expressed in neuronal cell bodies, 
especially in the cortex, hippocampus, hypothalamus, olfactory bulb, claustrum, amygdala, 
and thalamus; and inducible NOS is expressed in macrophages, glial cells, infiltrating neu‐
trophils, and, to some extent, neurons [1]. It has also been reported that eNOS can be found 
in a subset of neurons and astrocytes and that nNOS can be found at low levels in astrocytes 
[2]. Because these enzymes may have different sites of expression and activation, they have a 
pivotal role in the divergent functions of NO [3].
Several studies have demonstrated that NO, a freely diffusible gaseous compound, has an 
important role in a variety of neurobiological processes [4]. Numerous functions of this regu‐
latory molecule have been identified in the CNS, in the process of endothelium‐dependent 
vasodilatation [5–8], in neurotransmission [9, 10], and in host‐defense mechanisms [11, 12].
NO is produced from the oxidation of the terminal guanidine nitrogen of the amino acid 
arginine. This reaction is catalyzed by the NADPH‐dependent enzyme, nitric oxide synthase 
(NOS). After its formation, NO diffuses outside the cell [13]. NO derived from eNOS main‐
tains the CNS microcirculation [14] by inhibiting platelet aggregation and leukocyte adhe‐
sion and migration [15]. NO derived from nNOS is an important neurotransmitter related to 
neuronal plasticity, memory formation, regulation of CNS blood flow, and neurotransmitter 
release [16, 17].
2. Implications of nitric oxide synthase in the physiological central 
nervous system
Under physiological conditions, the concentration of NO fluctuates within the range of low 
values [18] and is produced mainly by nNOS and eNOS. Unlike the other two enzymes, iNOS 
is not expressed unless it is induced by inflammatory mediators, cytokines, and other agents, 
such as endotoxins [19]. Due to its calcium‐independent activation, iNOS can produce a large 
amount (100–1000 times greater) of NO in relation to eNOS and nNOS [20]. Until the enzyme 
is degraded, iNOS constitutively produces NO [21].
NO binds to guanylyl‐cyclase, which is a soluble NO receptor and, through cGMP‐medi‐
ated signaling, acts either as a post‐ or a presynaptic messenger [22]. As a neurotransmitter, 
NO may activate the cGMP‐dependent protein kinase G (PKG) pathway that phosphorylates 
synaptophysin, which is critical for fusion of presynaptic vesicles, thereby potentiating and 
facilitating neurotransmission [22] (Figure 1). NO also acts on inhibitory gamma‐aminobu‐
tyric acid (GABA)‐ergic synaptic transmission via cGMP‐dependent pathways as well as on 
ion channels and exchangers [9].
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The brain relies on a constant and adequate supply of oxygen and glucose that is provided by 
blood. Cerebral blood flow is altered in response to both neural activity and humoral stimuli 
(e.g., arterial PO
2
 and PCO
2
). Thus, augmented neural activation results in locally increased 
cerebral blood flow via functional hyperemia, whereas humoral stimuli produce overall 
increase in cerebral blood flow [23]. The physiological production of endothelium‐derived 
NO by eNOS is protective in hypoxic or ischemic brain injury.
All NOS isoforms have phosphorylation sites for different protein kinases, including protein 
kinase A, B, and C, and calcium‐calmodulin kinase [24]. NOS enzymes are very important for 
the maintenance of physiological mechanisms within an organism, and the genetic ablation 
of NOS in mice has been informative for establishing the functional roles of NOS‐generated 
NO in different systems [25]. For instance, nNOS‐KO mice present with intense gastroparesis 
due to impaired vagal innervation of stomach muscle cells [26], decreased apoptosis induced 
Figure 1. NO act as an unconventional neurotransmitter that is not stored in synaptic vesicles and not released upon 
membrane depolarization; it releases as soon it is synthesized and does not bind to any receptors, but diffuses from one 
neuron to another. NO stimulate soluble guanylyl‐cyclase to form the second messenger molecule, cyclic guanosine 
monophosphate (cGMP) either as a post‐ or a presynaptic messenger. PKG, protein kinase G; ERK, extracellular signal‐
regulated kinases; LTP, long‐term potentiation. Images: https://mindthegraph.com.
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by striatal N‐methyl‐D‐aspartate (NMDA) microinjections [27], and early dysfunction of hip‐
pocampal‐dependent spatial memory [28]. Additionally, disrupting the gene that encodes 
eNOS in mice‐induced spontaneous systemic and pulmonary hypertension [29] and inhibited 
growth factor‐mediated angiogenesis [30]. Thus, NO acts through numerous mechanisms of 
different physiological systems and in living cells.
Shortly after its identification, NO emerged as a possible mediator of neurovascular coupling. 
Neurovascular coupling is an active mechanism with vessel diameter alterations in response 
to increased metabolic demands from neuronal activity. Under these conditions, NO acts as 
a potent vasodilator that is released during enhanced neuronal activity and is well suited to 
mediate the coupling between neuronal activity and cerebral blood flow [31].
The importance of NO as an intermediary in cell communication in the brain is highlighted by the 
fact that the excitatory amino acid glutamate is an initiator of the reaction that forms NO. NO can 
act as a “double‐edged sword”. Whereas NO supports vascular homeostasis in the endothelium‐
dependent vasodilatation, its over‐ or underproduction is linked to pathological conditions [4].
3. Implications of nitric oxide synthase in the pathological central 
nervous system conditions
NO is also an important mediator under pathological conditions. For instance, in brain isch‐
emia‐reperfusion injury, NO formation is initially increased and has a protective function by 
inducing collateral perfusion as a result of its powerful stimulatory effect on vasodilatation 
and angiogenesis [32]. NO donors induce neuroprotective effects.
NO can exist in distinct oxidation/reduction states and present dual biological actions as 
either a neuroprotective or a neurotoxic molecule [4]. Under physiological conditions, nNOS 
produces hydrogen peroxide (H
2
O
2
) and superoxide (O
2
•−) in addition to NO [33].
The downstream cascade in the breakdown of the BBB appears to be mediated by eNOS activ‐
ity; the systemic administration of a selective eNOS inhibitor abrogates VEGF‐A‐induced BBB 
disruption and protects against neurologic damage in models of inflammatory disease [34, 
35]. Nevertheless, it was suggested that eNOS‐derived NO is a neuromodulator that partici‐
pates in the BBB‐mediated control of the cerebellum in experimental models [36].
Curiously, perivascular macrophage‐derived iNOS‐generated NO, that strategically localizes 
to leukocytes at brain penetration sites, can serve as a negative feedback regulator that pre‐
vents the unlimited influx of inflammatory cells by restoring BBB integrity [37].
In the brain, NOS regulates cerebral blood flow and neurotransmitter release, and the proper 
operative eNOS/NO system accounts for the microenvironment homeostasis that is essential 
for the normal functioning of neurons and glial cells [38]. Therefore, the NO produced by NOS 
results in vasodilation and controls vascular resistance, platelet adhesion and aggregation, 
leukocyte‐to‐endothelium interaction, and the maintenance of BBB integrity [36].
Several reports have indicated significant nervous system morbidity due to viral, bacterial, 
fungal, and parasitic infections (review [39]). During a systemic response to infections, cytokines, 
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chemokines, and damage‐associated soluble mediators of systemic inflammation can gain access 
to the CNS via blood flow [40]. These mediators can access the brain tissue after the disruption of 
the BBB. The presence of proinflammatory mediators leads to a disturbance of neuronal and glial 
homeostasis, with subsequent cognitive and behavioral manifestations that are common during 
acute infections (anorexia, malaise, depression, and decreased physical activity) and are collec‐
tively known as sickness behavior [40]. Although sickness behavior manifestations are transient 
and self‐limited, the cognitive and behavioral changes can become permanent or long‐lasting 
under a persistent systemic inflammatory response. For example, cognitive decline is a common 
consequence in sepsis and cerebral malaria survivors, as found in both clinical and experimental 
approaches.
Under healthy conditions, the main cell types that are present in the brain are neurons, oligo‐
dendrocytes, astrocytes, and microglia. Neurons connect to each other through long axonal 
processes with synapses to transmit electrical/chemical signals, thereby generating memory 
and emotions that are associated with learning, and to control organ and systemic functions. 
Oligodendrocytes support axons with myelin sheaths. Astrocytes interact with blood vessels 
to form the BBB and maintain neuronal synapses. Microglia form long processes to phagocyte 
apoptotic cells and prune inactive synapses without inducing inflammation while maintaining 
a type of surveillance of neurons. Systemic inflammatory conditions result in the disruption of 
the BBB and the efflux of proinflammatory cytokines/chemokines as well as pathogen‐associ‐
ated molecular patterns (PAMPs) and danger‐associated molecular patterns (DAMPS), which 
together activate glial cells. This results in an inflammatory environment due to the release 
of cytokines/chemokines and reactive oxygen/nitrogen species that exert direct and indirect 
neuronal cytotoxic effects [40, 41]. Oligodendroglial myelin sheaths can be affected, thereby 
leading to axonal degeneration. Astrocytosis leads to reduced BBB and synaptic maintenance. 
Microgliosis results in a proinflammatory microglial phenotype with reduced tissue mainte‐
nance functions [41, 42]. Neuronal cells can develop an excitotoxicity process due to excessive 
glutamate in the synaptic cleft and subsequent extra‐synaptic NMDA receptor activation that 
results in a subsequent increase of Ca2+ efflux in neuronal cells and the activation of proteins 
calpain 1 and neuronal nitric oxide. This results in mitochondrial dysfunction and oxidative 
damage by reactive oxygen and nitrogen species [43]. Together, these mechanisms lead to 
neuronal death, thereby contributing to long‐term cognitive decline, which has been shown 
to be a consequence of several infectious diseases.
As shown in Figure 2, the gaseous signaling molecule NO has a variety of cellular functions, 
including neurotransmission, regulation of blood‐vessel tone, and immunity. Under patho‐
logical conditions, free radicals may deplete NO produced by eNOS through the formation of 
ONOO−, thus decreasing the vascular bioavailability of NO, which results in BBB dysfunction. 
This ultimately results in endothelial damage, edema development, and hypoxia. Furthermore, 
the NO produced by iNOS in glial cells or by nNOS under excitotoxic process can form with 
free radicals (particularly O
2
−) ONOO− and produce several deleterious effects on tissue, such 
as through tyrosine nitration and cysteine oxidation in various proteins. These free radicals can 
further decompose into highly toxic‐free radicals, such as NO
2
• and •OH (as reviewed by [44]).
Nitric oxide, as described above, is a key molecule in the regulation of physiological brain 
homeostasis. Nitric oxide is synthetized by neuronal vessels (eNOS), by neurons (nNOS) 
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under physiological/pathological stimuli, and by iNOS during inflammatory conditions. It 
is well known that high levels of nitric oxide (NO) released by the inducible NO synthase 
(iNOS) are critical for defense against parasites and mediate inflammatory tissue damage. 
However, the suppression or lack of NO production results in the impaired clearance of some 
types of bacteria by the host [45].
Our group and others have shown that eNOS is impaired during systemic infection, which 
leads to brain microcirculation dysfunction [46–48]. We showed that during different infec‐
tious diseases, there is a functional capillary rarefaction (Figure 3) that can be caused by the 
impairment of endothelial NO production by a reduction of eNOS activity or by reduced 
levels of the enzyme cofactor tetrahydrobiopterin—BH4 [49].
Figure 2. Different steps in the NO signaling cascade under physiological/pathological conditions in the brain. 
During long‐term potentiation, NOS1 or neuronal NOS (nNOS) catalyze the NO synthesis after the activation of the 
NMDA receptor by Ca2+. Under excitotoxic conditions, excessive Ca2+ leads to nNOS hyperactivity, whereas excessive 
NO production can combine with superoxide to form peroxynitrite, which is responsible for tissue damage due to 
several biological effects, including blockage of the eNOS pathway and BBB impairment. NO is synthesized following 
the transcriptional expression of a Ca2+‐independent NOS2 or iNOS isoform in glial cells (astrocytes and microglia) 
after cytokine exposure, thereby contributing to neuroinflammation and tissue damage in the brain. Intracellular Ca2+ 
activates NOS3 or eNOS to release NO from brain microvessels. This NO binds to soluble guanylyl‐cyclase (sGC) 
receptors, which triggers a cGMP‐dependent pathway and interacts with its downstream mediators of the physiological 
regulation of vasodilation and vascular resistance, platelet adhesion and aggregation, leukocyte‐endothelial interaction, 
and BBB integrity maintenance. Images: https://mindthegraph.com.
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Vascular function can be evaluated by the vasodilator response of cerebral arterioles to ace‐
tylcholine (Ach). Our group used intravital microscopy to evaluate the response to Ach in 
sepsis and Chagas’ disease model. The vasodilation‐to‐Ach test is directly related to the avail‐
ability of endothelium‐derived NO generated from l‐arginine by the action of endothelial 
NO synthase (eNOS). The diffusion of NO to vascular smooth muscle cells and the activation 
of guanylyl‐cyclase resulted in cGMP‐mediated vasodilation. However, the vasoconstrictive 
response to Ach results from a direct muscarinic smooth muscle effect [50]. This vasoconstric‐
tive effect can lead to the slow delivery of oxygen to brain tissue, generating hypoxia and 
increased glycose consume by glycolytic pathway to generate ATP for neuronal functioning. 
Consequently, mitochondrial function is compromised by low O
2
 concentration [51].
In both sepsis and Chagas’ disease models, we observed a vasoconstrictive response to Ach. One 
mechanism of eNOS “uncoupling” from the reduction of NO production and ROS generation 
involves the oxidative degradation of the cofactor BH4 (tetrahydrobiopterin), especially by per‐
oxynitrite (ONOO−), which is produced in association with superoxide and nitric oxide. Several 
studies have shown that there is an increase in impaired eNOS‐derived oxidative stress in brain 
tissue exposed to systemic infection, NO consumption and capillary dysfunction [46, 47, 52, 53].
Interestingly, in experimental models of malaria [48] and sepsis (Reis et al., submitted) blood 
flow was recovered by treatment with statins. As reviewed by Giannopoulos et al. [54], statins 
are shown to enhance eNOS expression and can contribute to the restoration of brain capil‐
lary function.
Figure 3. Photomicrography from intravital microscopy showing capillary impairment (red arrows) under healthy (A) 
and infectious conditions (B) malaria, (C) sepsis, and (D) Chagas’ disease [47, 48].
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Resident glial cells in the CNS (i.e., astroglia and microglia) express inducible nitric oxide 
synthase (iNOS) and produce high levels of NO in response to a wide variety of proinflam‐
matory and degenerative stimuli. Excessive NO production by glial cells evoked by inflam‐
matory signals contributes to the pathogenesis of several neurodegenerative diseases, 
such as multiple sclerosis, HIV dementia, brain ischemia, trauma, Parkinson's disease, and 
Alzheimer's disease. NO can also be released in glial cells in response to infectious agent. 
The inducible form of nitric oxide synthase can be strongly associated with tissue damage, 
despite its activity as an antimicrobial agent. As reviewed by Saha and Pahan [55], astrocytes 
and microglia can express iNOS and synthetize NO. According to Radi [56], nitric oxide can 
combine with superoxide (produced mainly by the NADPH oxidase system and partially 
by mitochondria) under conditions of oxidative stress. It is common under neuroinflamma‐
tory conditions to form peroxynitrite, which binds to tyrosine to produce 3‐nitrotyrosine, 
and a marker of reactive nitrogen species production. The reactions of peroxynitrite with 
biomolecules can lead to cytotoxic events and may result in apoptotic or necrotic cell death. 
Peroxynitrite can act via antioxidant enzyme inhibition; antioxidant depletion; protein aggre‐
gation (e.g., α‐synuclein and microtubule‐associated tau protein modifications in the CNS); 
activation of specific enzymes (e.g., matrix metalloproteinases (MMPs), cytochrome c, glu‐
tathione‐S‐transferase, protein kinase C‐ε (PKCε), and fibrinogen); impairment of enzyme 
cofactors (e.g., BH4); modification of mediator pathways, receptors, and cellular signaling 
molecules; calcium deregulation; DNA injury; and mitochondrial dysfunction, among other 
processes (reviewed by [57]).
Data from our group show that the absence of the iNOS enzyme (knockout) or treatment with 
iNOS‐specific inhibitors (e.g., aminoguanidine) has a beneficial effect on the prevention of 
cognitive impairment (unpublished data) in experimental cerebral malaria. This could be due 
to the reduced production of the peroxynitrite radical and the subsequent reduction of tissue 
damage. Other studies are being conducted to clarify the impact of the synthesis of nitric 
oxide by iNOS in infectious diseases and in the development of cognitive decline. Weberpals 
et al. also observed that iNOS gene deficiency prevents cognitive decline in addition to pro‐
moting a reduction in gliosis (astrocytes and microglia), proinflammatory cytokines TNF‐α 
and IL‐1β release, and reduction of synaptic dysfunction in sepsis model [58].
4. NMDA‐nNOS pathway and excitotoxicity development
The NMDA receptor is a key regulator during glutamatergic long‐term potentiation (LTP) 
response. During physiological conditions, glutamatergic ionotropic (e.g., kainate, NMDA, 
and AMPA) and metabotropic receptors (mGlut) are activated, delivering Ca2+ into neuronal 
cells and resulting in depolarization and the triggering of mitogen‐activated protein kinase 
(MEK)/extracellular signal‐regulated kinase (ERK) and phosphatidylinositol 3‐kinase (PI3K) 
signaling pathways. This then activates phosphoinositide‐dependent kinase 1 or 2 (PDK1/2), 
Akt, and mammalian target of rapamycin (mTOR) downstream signaling [59]. Additionally, 
calcium‐dependent kinase II (CAMKII) is rapidly activated and all events together lead to the 
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activation of transcription factors (e.g., CREB) and an increase in the synthesis of neurotrophic 
factors (e.g., BDNF) and proteins associated with the long‐term potentiation (LTP) process.
Despite the major activity of NMDA receptors in LTP, several reports have related this recep‐
tor with excitotoxicity, which is a neurodegenerative process. This process has been associ‐
ated with a different class of NMDA receptor: the extra‐synaptic receptor. As reviewed by 
Parsons and Raymond, synaptic NMDA (which expresses the subunit GlutN2A) is associated 
with LTP, whereas extra‐synaptic receptors (which express the subunit GlutN2B) is associ‐
ated with excitotoxicity and cell death [42]. NMDARs recruit the calcium‐dependent enzyme 
nNOS via PSD95 (postsynaptic density: membrane‐associated guanylate kinase (MAGUK) 
scaffolding protein located in neural postsynaptic densities), which is also associated with 
the LTP process. This is considered a key contributor to excitotoxicity lesions in both stroke 
and neurodegenerative diseases [60]. nNOS is activated by calcium/calmodulin signaling and 
is PSD95 protein‐dependent [60]. During excitotoxicity, the activation of NMDA enhances 
intracellular calcium, leading to nNOS activation and NO production. Additionally, excessive 
intracellular calcium activates calpain 1, which then disrupts mitochondrial function, thereby 
triggering the intrinsic apoptotic pathway by releasing cytochrome C and activating apopto‐
somal protein complex [61]. NO can combine with superoxide, which results in peroxynitrite 
formation and cellular damage. Peroxynitrite can disturb cellular function by the nitration 
of proteins, which reduces or eliminates protein function, as described earlier, and by DNA 
damage via the activation of poly (ADP‐ribose) polymerase 1 (PARP‐1). The impact of PARP‐1 
on intracellular concentration of its nicotinamideadenine dinucleotide substrate (NAD), cre‐
ates a bioenergetic imbalance that culminates with ATP depletion, thereby triggering necrotic 
neuronal death [62, 63]. In addition, NO can drive the retraction of the synaptic button via 
the activation of small GTPase RhoA/ROCK signaling through a paracrine/retrograde‐signal‐
ing pathway [64]. Taken together, these events could contribute to neuronal dysfunction and 
death associated with cognitive decline.
The roles of NO in neuronal damage following insults, such as hypoxia, traumatic brain injury, 
and ischemia, have been well established. Recent evidence has implicated an imbalance of 
ROS and NO signaling in neurodegenerative disorders, such as Alzheimer's disease and 
Parkinson's disease, and in cognitive impairments associated with normal physiological 
aging [65–67]. Whereas mild oxidative/nitrosative (nitric oxide (NO)‐related) stress mediates 
normal neuronal signaling, the accumulation of free radicals is associated with neuronal cell 
injury or death.
As described above, NO from eNOS modulates blood flow in the brain, and its impairment 
could be associated with hypoxic events in the brain. Several degenerative and infectious 
diseases relate hypoxia to neuronal dysfunction and cognitive decline. Using partial eNOS 
knockout mice model, Tan et al. [68] showed that the development of spontaneous thrombotic 
cerebral infarction is followed by amyloid protein deposit and cognitive decline. Cognitive 
decline is a major cause of disability in stroke survivors [69]. We have shown that microvascu‐
lar impairment in malaria, sepsis, and Chagas’ diseases may occur in response to other infec‐
tious agents [46–48]. Cerebral metabolism is dependent upon the glucose and oxygen that are 
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delivered by blood, and it is clear that alterations in endothelial function can disrupt neuronal 
functions. Additionally, activation of endothelial cells by systemic cytokines, PAMP/DAMP 
and prooxidant molecules can contribute to eNOS dysfunction [70], blood flow disturbance 
and neuronal dysfunction, which subsequently results in cognitive decline.
The activation of glial cells that may be related with systemic inflammation associated to host 
response to pathogens can activate inducible isoforms of iNOS and subsequently generate 
cellular damage via the generation of peroxynitrite by the combination of NO and superox‐
ide radicals. In this way, the induction of iNOS may result in the development of cognitive 
impairment [71]. Experimental models of sepsis [58] and malaria (unpublished data) have 
shown that the inhibition of iNOS has a beneficial effect on the central nervous system, par‐
ticularly by abolishing cognitive decline.
The main enzyme target in the central nervous system seems to be nNOS. The NO generated 
by nNOS controls the release of neurotransmitters and is involved in synaptogenesis, synap‐
tic plasticity, memory function, and neuroendocrine secretion. However, the overproduction 
of NO during NMDA‐excitotoxic events can lead to neuronal death and directly impact the 
cognitive function.
Death pathways are activated in mouse brains during experimental model of sepsis and 
malaria [72, 73]. Additionally, reduced levels of neurotrophic factors, impairment of neurogen‐
esis, and synaptic dysfunction were observed [74–78]. However, the role of excitotoxicity and 
nNOS delivery during infectious diseases and long‐term cognitive impairment is not yet clear. 
Neuroinflammation can also induce cell damage/death, and the modulation of the activation 
of glial cells has been suggested to prevent neuronal damage and cognitive decline. Cognitive 
impairment is prevented by antioxidants and statin treatment [48, 53, 79], which suggests that 
the control of oxidative or inflammatory damage is also efficient to avoid cognitive decline.
5. Conclusion
NO is a key molecule involved in the regulation of CNS function in health and disease 
(Table 1). The impairment of enzymatic activity or the overproduction of NO under inflamma‐
tory/excitotoxic conditions can contribute to neurological sequela during systemic‐infectious 
diseases (Figure 3). The NO synthase complex can be considered a target of pharmacologi‐
cal intervention focusing on the prevention of cognitive sequela; however, this field requires 
further studies.
NOS isoform Physiological effect on CNS Pathological effect on CNS
nNOS Learning and memory ↑—Neuronal death by excitotoxicity
eNOS Vasodilation and increased blood flow ↓—Hypoxia
iNOS Sleep [33] ↑—Tissue damage
Table 1. Nitric oxide synthase enzymes functions on health/pathological conditions.
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